Glycopeptide Antibiotics Global Market Report 2024: Forecast to Reach $5.02 Billion by 2028 - Long-term Forecast to 2028 and 2033
January 25, 2024 04:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics...
ZINPLAVA (Bezlotoxumab) Drug Insight and Market Forecasts, 2019-2032: Developed by Merck Sharp & Dohme, A Human Monoclonal Antibody that Binds to C
January 24, 2024 08:17 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ZINPLAVA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed picture...
DIFICID (Fidaxomicin) Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A Macrolide Antibiotic Used to Treat CDAD - Focus on United States, Germany, France, Italy, Spain, UK, and Japan
January 24, 2024 08:16 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DIFICID Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed picture of...
With 2.5% CAGR, Global Antibiotics Market Size, Share & Growth Analysis, [2028]
December 13, 2023 06:44 ET
|
Fortune Business Insights
Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Global Antibiotics Market Size was valued at USD 37.35 billion in 2020 and is projected to grow USD 45.30 billion by 2028 exhibiting a CAGR of 2.5%...
Microbial Fermentation Technology Market revenue to hit USD 63 Billion by 2036, says Research Nester
December 06, 2023 06:00 ET
|
Research Nester
New York , Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global microbial fermentation technology market size is expected to expand at 6% CAGR from 2024 to 2036. The market is anticipated to garner a...
Er-Kim Pharmaceuticals Supports Worldwide Prevention of Antimicrobial Resistance (AMR)
November 24, 2023 08:00 ET
|
Er-Kim Pharmaceuticals
Er-Kim Pharmaceuticals joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6
November 20, 2023 04:00 ET
|
AKAMPION
- Phase I data show safety and tolerability at clinically significant dose levels- New class of anti-infectives to treat infections with Gram-negative bacteria JERUSALEM, Israel, November 20,...
Animal Antibiotics and Antimicrobials Market is Expected to Reach $5.6 billion | MarketsandMarkets.
November 14, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Animal Antibiotics and Antimicrobials market in terms of revenue was estimated to be worth $4.7 billion in 2021 and is poised to reach $5.6 billion by...
Microbiome Therapeutics Market Size to Hit $813.38 Million, Globally, by 2030 - Exclusive Report by The Insight Partners
November 10, 2023 05:43 ET
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbiome therapeutics, also referred to as microbiome-based therapies or interventions, are medical procedures that try to use the human microbiome's...
Eye Drops Market Share Worth $23.78 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 30, 2023 04:34 ET
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eye drops are most often saline solutions with medications in them to treat various conditions of the eye. Sometimes, they contain no medication and...